Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Sonoclear AS currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This 1 pending office action is assigned to 1 distinct examiner and is being processed within 1 distinct art unit. The presence of 1 distinct art unit for the pending action suggests a specific technical classification for the current patent applications. This arrangement indicates that the current intellectual property strategy is directed toward the technical field as defined by this patent office division.
Practitioners should note that the prosecution process is subject to the specific examination style and preferences of the 1 distinct examiner. The alignment of 1 distinct examiner with 1 distinct art unit provides a point of contact for current patent office interactions, requiring a strategy tailored to the history of the busiest examiner, BAEK, JONGHWAN NMN. This examiner is responsible for 1 busiest examiner pending office action. Since BAEK, JONGHWAN NMN handles the 1 busiest examiner pending office action, this individual manages the company's active prosecution matters. This concentration under this examiner means that the patent outcomes are currently tied to this point of review.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAEK, JONGHWAN NMN | 1 | 50.0% | +0.0% |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18712472 | ULTRASOUND COUPLING AGENT | BAEK, JONGHWAN NMN | 1618 | §103DP | Non-Final OA | — | Pending | May 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSonoclear AS has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jonghwan Nmn Baek has the most, with 1 of Sonoclear AS's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
